FDA feedback confirms Adial’s proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging requirement for…
BOSTON, Feb. 24, 2025 /PRNewswire/ -- Q2i, a leader in digital innovation, has announced that its contingency management division (CMI)…
DENVER, Feb. 20, 2025 /PRNewswire/ -- SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), the leader in next-generation alcohol detection technology, and Orbiit, an…
New Patent covers claims which focus on method for identifying genetic markers in patients with alcohol or opioid related disorders…
Strategic partnership with Paradromics will accelerate advancements in brain-computer interfaces and establish a Center of Excellence in NEOM. AUSTIN, Texas,…
Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer’s disease with MK-1167, an α7 nicotinic…
West end Toronto emergency department is 40% larger, fully donor-fundedTORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- St. Joseph’s Health Centre…
SEATTLE and VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical…
MIAMI, Feb. 10, 2025 /PRNewswire/ -- The Digital Safety Alliance (DSA) is proud to celebrate its one-year anniversary with the…
No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure Trial Achieve Reiterates Planned Cytisinicline NDA Submission in Q2…